How to Pull the Right Regulatory Levers

Interview with Linear Health Sciences Founder and President Daniel Clark

Dan Clark is no stranger to setbacks. His medtech startup, Linear Health Sciences, spent years navigating the regulatory waters, but that didn't stop him or his team.

Like many medtech company founders, Dan was technical by training. He started out his career in the private sector at Parker Hannifin — “the biggest company nobody’s ever heard of,” he says. Although the company had a small medical device segment, the industry wasn’t on his radar.

But after diving deeper into the medtech space, he learned about the innovation cycle and eventually managed strategic relationships toward the end of his tenure.

He got antsy, though, and was itching to innovate.

“I can't stand the idea of not having a new innovative way to do things or a different perspective,” he explains. As he considered his next steps, he knew that eventually, he wanted to start something himself. The right opportunity — what would become Linear — came about in 2015 when a friend introduced him to a physician with an idea that seemed to be right up Dan’s alley.

The initial concept pitch evolved into the Orchid Safety Release Valve. Co-founded by Dan and Dr. Ryan Dennis, Linear is shifting the standard of care for medical tubing dislodgement. In this episode of Medsider, Dan explains when and how Linear raised capital, how it has navigated complex regulatory pathways, and why you need to be your own worst enemy as an innovator.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest